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Abstract 
Introduction 
A common method of learning about adverse events(AEs) is by reviewing medical records 
using the global trigger tool(GTT). However, these studies generally report rates of harm. 
The aim of this study is to characterise paediatric AEs detected by the GTT using descriptive 
and qualitative approaches. 
Methods 
Medical records of children aged 0-15 were reviewed for presence of harm using the GTT. 
Records from 2012-2013 were sampled from hospital inpatients, emergency departments, 
general practice and specialist paediatric practices in three Australian states. Nurses 
undertook a review of each record and if an AE was suspected a doctor performed a 
verification review of a summary created by the nurse. A qualitative content analysis was 
undertaken on the summary of verified AEs. 
Results 
A total of 232 AEs were detected from 6,689 records reviewed. Over four-fifths of the AEs 
(192/232, 83%) resulted in minor harm to the patient. Nearly half (112/232, 48%) related to 
medication/intravenous(IV) fluids. Of these, 83% (85/112) were adverse drug reactions. 
Problems with medical devices/equipment were the next most frequent with nearly two-thirds 
(32/51, 63%) of these related to intravenous devices. Problems associated with clinical 
processes/procedures comprise one in six AEs (38/232, 16%), of which diagnostic problems 
(12/38, 32%) and procedural complications (11/38, 29%) were the most frequent.   
Conclusion 
Adverse drug reactions and issues with IVs are frequently identified AEs reflecting their 
common use in paediatrics. The qualitative approach taken in this study allowed AE types to 
be characterised, which is a prerequisite for developing and prioritising improvements in 
practice.   
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Introduction  
A high-quality health system should deliver care that is free from avoidable harm to patients. 
However, despite 20 years of focus by policy makers, clinicians and researchers, patients 
continue to suffer adverse events.1 Most studies on adverse events are focussed on adult 
care.2, 3 However, increasingly, care for children is being studied. For example, in children, 
seven studies in five countries show rates of hospital admissions associated with an adverse 
event to range from 5 to 34%.4-10 In three studies, where measured, adverse events are 
estimated to be preventable in 44%, 50% and 78% of cases.5, 8, 9 Few studies of adverse 
events have been undertaken in children’s healthcare in Australia.2, 11  
One method that has been used to detect, count and characterise adverse events is medical 
record review.12 One medical record review technique is the Institute of Healthcare 
Improvement’s (IHI) Global Trigger Tool (GTT) which was developed for use in hospitals.12 
The GTT uses occurrences, prompts or flags (“triggers”) that may suggest an adverse event 
has occurred and serve as a cue for reviewers to investigate further.12 The GTT is modifiable 
and has been adapted for use by customising sets of triggers in paediatric hospitals, neonatal 
intensive care units, paediatric intensive care units, paediatric otolaryngology and primary 
care.4-7, 10, 13-19  
Studies on adverse events in children using the GTT have focussed mainly on counting harm 
rather than characterising events.4, 6, 7, 10 They describe the severity of harm, the triggers and 
their positive predictive values.4, 6, 7, 10 However, we do not understand, in detail, the incident 
types that children are exposed to, and are detected by, the GTT.  
The CareTrack Kids program was designed to determine the quality of care of Australian 
children aged 0 to 15 years received for 17 common conditions from a range of Australian 
paediatric healthcare practice types (hospital, general practice and specialists) over a two year 
period from 2012 to 2013.20 The CareTrack Kids findings have been reported elsewhere.20 As 
a related study to CareTrack Kids, this study set out to characterise paediatric adverse events 
detected with the GTT, using descriptive and qualitative approaches, which are related to at 
least one of the 17 CareTrack Kids conditions.  
Methods 
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The main stages of the study are outlined below. Inclusion criteria were determined, health 
services were recruited and sampled, medical records were sampled, and then data collected 
and analysed. Further details of the sampling strategies are provided in our paper outlining 
the results of assessing the quality of care delivered to children in Australia.20 
Inclusion criteria 
Children aged <16 years who were managed for at least one of 17 CareTrack Kids conditions 
were included in the study. CareTrack Kids conditions were identified on the basis of 
published research,21, 22 burden of disease,23 prevalence, frequency of presentation and 
national priority areas.24-26 The 17 conditions were: acute abdominal pain, acute 
bronchiolitis, acute gastroenteritis, anxiety, asthma, attention deficit hyperactivity disorder 
(ADHD), autism, croup, depression, diabetes, eczema, fever, gastro-oesophageal reflux 
disease (GORD), head injury, otitis media, tonsillitis, and upper respiratory tract infection 
(URTI).20  
Sampling strategy 
A multistage, randomised stratified sampling plan was designed.20 Three Australian states 
(Queensland, New South Wales and South Australia) which comprise 60% of the Australian 
population aged <16 years were sampled. Care provided to children as inpatients, in 
emergency departments, general practice, and specialist paediatric practices was assessed. A 
pre-specified number of medical records was selected from each healthcare provider type, 
which aimed to achieve the initial sampling target of 400 per condition; anxiety and 
depression were treated as a single condition for sampling purposes.  
Recruitment of health care providers  
Health care providers were recruited by direct mail, telephone and face-to-face contact. 
Within the selected states, we targeted all hospitals that had the minimum patient volumes;27 
34 of 37 (92%) of eligible hospitals that were approached agreed to participate.20 General 
practices and specialists paediatric practices were recruited through advertising, internet 
searches, and personal contacts; non-responses and refusals were not tracked, so response 
rates cannot be calculated.  
Sampling of medical records 
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Health care providers sent to the researchers electronic lists of medical record numbers of 
patients whom they identified as having one of the CareTrack Kids conditions from the ICD-
10-AM (International Classification of Diseases, Tenth Revision, Australian Modification), 
SNOMED (Systematised Nomenclature of Medicine), or their own classification system in 
their patient management system. The study team then randomly selected patient record 
numbers from these.  
Data collection and associated tools  
We used a modified version of the GTT to collect data. GTTs use a series of ‘triggers’ to 
screen a medical record for a potential adverse event. The presence of a trigger signals the 
need for an in-depth review.  
Collate and ratify triggers 
Triggers applicable to Australian paediatric healthcare settings were developed. We searched 
the literature to collate existing paediatric tools and triggers5-8, 10 and generated three lists of 
candidate triggers - one for hospital use (encompassing emergency department visits and 
inpatient admissions), one for general practices and one for specialist paediatric practices. 
Using a two-round Delphi process, 15 specialist paediatricians and 5 general practitioners 
voted on the most applicable triggers within the three lists. The final three lists of triggers are 
shown in Appendix 1.  
Data collection tool 
A module was added to a web-based tool developed for the CareTrack Australia study27-30 to 
include the collection of adverse events. The tool enabled data to be entered during the 
review of the medical records and enable subsequent data analysis. The tool was hosted on 
dedicated laptop computers which supported secure data access, data encryption, offline data 
collection and subsequent database synchronisation to mitigate against the problems of fire 
walls and poor internet connectivity in various healthcare settings.  
Surveyors and reviewers 
Two types of researchers were involved in the data collection: ‘surveyors’ and ‘medical 
adverse event reviewers’. Nurses were employed to simultaneously act as surveyors for this 
study and the parallel study of appropriateness of care.20, 27 Nine surveyors, all experienced 
7 
 
registered paediatric nurses, were engaged across the three states, and underwent five days of 
training and competency assessment. Surveyors reviewed medical records manually on-site at 
each healthcare provider during March–October 2016. As healthcare providers were 
separated by up to 3,000 kilometres, the standard GTT protocol of two nurses assessing each 
record12 and assessment of inter-rater reliability between surveyors on real records was not 
feasible. Medical practitioners were recruited as ‘medical adverse event reviewers’ to 
undertake a confirmation review of the information collected and recorded by the surveyor.  
Data collection process 
Surveyors conducted reviews of medical records using all available information relating to 
patient visits or admissions including discharge summaries, tests and investigations and 
letters.12 Medical records relating to the calendar years 2012-2013 were reviewed. For 
hospital inpatient admissions and emergency department presentations, one index admission 
or presentation related to the CareTrack Kids condition was reviewed. If a child had more 
than one admission in the two-year period, a random number was generated and the notes for 
the corresponding visit were reviewed. For general practices and specialist paediatric 
practices, all admissions associated with CareTrack Kids conditions were reviewed. The 
surveyors did not have access to healthcare providers’ incident reporting systems.  
If a surveyor did not detect any triggers, the review was considered complete. If one or more 
triggers were detected, the surveyor undertook an in-depth review of the record to search for 
adverse events. If a surveyor detected a potential adverse event, they recorded it. The medical 
adverse event reviewer was then notified, securely entered the web-based tool, reviewed the 
information supplied by the surveyor, and provided a judgement on the presence of an 
adverse event.  
Data fields 
If a trigger was positive within a medical record, the following data fields were recorded: 
positive trigger: a free text field describing the circumstances of the potential adverse event; a 
description of the healthcare provider type that the adverse event primarily originated 
(community was added for adverse events that occurred outside of formal healthcare provider 
facilities e.g., an insulin pump failure at home); incident type from the WHO’s International 
Classification for Patient Safety (ICPS);31 and level of outcome or severity using the National 
Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) scale.32 
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Analysis of data 
A qualitative content analysis was undertaken,33 which allowed both deductive and inductive 
analytic approaches to be incorporated. For this analysis, we followed the items in the 
Standards for Reporting Qualitative Research: A Synthesis of Recommendations (SRQR)34. 
Two researchers (PH, AD) undertook the analysis. Both researchers had over 15 years of 
experience reviewing and analysing patient safety data including incident reports, coroner’s 
reports, root causes analysis reports, and medico-legal claims. The descriptive reports of the 
adverse events written by the surveyors in the three most frequently occurring incident types 
(Table 1) were analysed separately. The two researchers iteratively read each adverse event 
and extracted themes or concepts related to the relevant incident type, and then developed 
consensus.35 Different themes were developed for each incident type and were described.  
The reasons for not attempting to measure rates of harm were that: the GTT protocol states 
that the tool is not designed to collect all adverse events;12 the highly disparate rates of 
adverse events reported in studies and the reasons for these differences are methodological 
differences and disparate reviewer interpretations;2 data were collected from different types 
of healthcare providers types; the adverse events had origins in different healthcare providers 
so a denominator was not able to be calculated; and the GTT should be used primarily as a 
method to characterize the most frequent types of adverse events for prioritization for quality 
improvement.2, 36, 37 
Ethical Approval 
Ethics approval was obtained from hospital networks and individual hospitals in each 
sampled state (Sydney Children’s Hospital Network: HREC/14/SCHN/113, Children’s 
Health Queensland Hospital and Health Service: HREC/14/QRCH/91, Women’s and 
Children’s Health Network: HREC/14/WCHN/68), and the Royal Australian College of 
General Practitioners (NREEC 14-008). Australian human research ethics committees can 
waive requirements for patient consent for external access to medical records if the study 
entails minimal risk to facilities, clinicians, and patients; all relevant bodies provided this 
waiver. Ethical approvals for this study do not permit reporting of overall performance by 
health care provider. Participants were protected from litigation by gaining statutory 
immunity for this study as a quality assurance activity from the Federal Minister for Health 
under Part VC of the Australian Health Insurance Act 1973. 
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Results 
A total of 232 adverse events were collected by surveyors and ratified by medical reviewers 
from 6,689 records. Nearly half of the adverse events related to medication/intravenous (IV) 
fluids (112/232, 48%)(Table 1). Medical devices/equipment was the next most frequently 
recorded incident type with nearly two-thirds (32/51, 63%) of these adverse events related to 
problems related to IV devices such as infiltration (not shown in tables). The most frequent 
CareTrack Kids condition where management of the condition was directly associated with 
an adverse event was diabetes (22/232, 9%)(not shown in tables).  
Table 2 describes the origin of the adverse events by healthcare provider type. Nearly half 
(109/232, 47%) originated in hospital. For specialist paediatricians and general practices, 
most adverse events related to medication (21/22 (95%) and 52/59 (88%) respectively). For 
hospitals, medical devices/equipment comprise 42% (46/109) of adverse events, compared to 
22% (51/232) of all adverse events. Clinical process or procedure problems comprised one in 
six of all adverse events (Table 1, 38/232, 16%) but more than one in three of those in 
emergency departments (11/29, 38%). Over half of clinical process or procedure (6/11, 55%) 
adverse events in emergency departments related to diagnosis or assessment and over half 
(12/21, 63%) in hospital inpatients related to procedures or treatments (not shown in tables).  
Table 1: Adverse event incident types (n, %) 
Incident types Total % 
Medication/IV Fluids 112 48 
Medical Device/Equipment* 51 22 
Clinical Process/Procedure^ 38 16 
Healthcare Associated Infection 12 5 
Patient accidents 9 4 
Behaviour 4 2 
Falls 3 1 
Resources/Organizational Management 2 1 
Clinical Administration 1 <1 
Total 232 100 
* Associated with equipment insulin pumps, tourniquet use, intravenous catheters 
^For example, diagnostic error or procedural complications 
 
Table 2: Adverse event origins and incident type (n, %), three most frequent incident types 
  
Hospital 
inpatients 
General 
practice 
Emergency 
department 
Specialist 
paediatric Community Total 
 25 (23) 52 (88) 12 (42) 21 (95) 2 (15) 112 (48) 
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Medical 
Device/Equipment 46 (42) 0 (0) 1 (3) 0 (0) 4 (31) 51 (22) 
Clinical 
Process/Procedure 21 (18) 4 (7) 11 (38) 1 (5) 1 (8) 38 (16) 
Other  17 (17) 3 (5) 5 (17) 0 (0) 6 (46) 31 (14) 
Total 109 (100) 59 (100) 29 (100) 22 (100) 13 (100) 232 (100) 
 
There were three adverse events in the highest severity categories G and H (Table 3). These 
related to: a difficult intubation of a child needing resuscitation, leading to a cardiac arrest; 
delay in diagnosis of a brain tumour; and bilateral methicillin-resistant Staphylococcus aureus 
(MRSA) otitis media acquired in a paediatric intensive care unit. Of the 36 Category F 
adverse events, 40% were clinical process/procedures (compared with 16% of all adverse 
events), about one quarter related to medication/IV fluids (8/36, 24%) compared with 48% of 
all adverse events, and one-sixth (6/37, 16%) comprised healthcare associated infections, 
compared with 5% of all adverse events.  
Table 3: NCC MERC Index of severity ratings (n, %) 
Category n % 
Category E: An error occurred that may have contributed to or resulted in 
temporary harm to the patient and required intervention 193 83 
Category F: An error occurred that may have contributed to or resulted in 
temporary harm to the patient and required initial or prolonged hospitalization 36 16 
Category G: An error occurred that may have contributed to or resulted in 
permanent patient harm 1 0 
Category H: An error occurred that required intervention necessary to sustain 
life 2 1 
Total 232 100 
Medication adverse events 
The most frequent medication adverse event was adverse drug reactions (93/112, 83%) 
followed by “wrong dose” (7/112, 6%). Table 4 outlines the frequency of adverse drug 
reactions by known medication class. Over half relate to antibiotics (41/76, 54%) (see Table 
5, AE#1 for an example) with the next most frequent class being central nervous system 
(CNS) stimulants (13/76, 17%) (Table 5, AE#2) and vaccination (13/76, 12%). These three 
classes comprise 83% of the adverse drug reactions. Of the antibiotic adverse drug reactions, 
over half related to the management of otitis media (12/41, 30%) or tonsillitis (10/41, 24%) 
(not shown in tables). For the CNS stimulant ADRs, 11/13 were for the management solely 
of ADHD, with the remaining two being for a combination of ADHD and autism.  
Table 4: Medication class of adverse drug reactions (number and %)* 
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Medication class n % 
Antibiotic 41 54 
Central nervous 
system stimulant 13 17 
Vaccination 9 12 
Selective Serotonin 
Reuptake Inhibitor 2 <3 
Steroid 2 <3 
Anaesthetic 1 <2 
Analgesic 1 <2 
Anticonvulsant 1 <2 
Anti-psychotic 1 <2 
Contraceptive 1 <2 
Laxative 1 <2 
Paracetamol agonist 1 <2 
Proton pump inhibitor 1 <2 
Psychotropic agent 1 <2 
Total 76 100 
* The medication class of 17/93 or 18% of adverse drug reactions was unknown 
 
Table 5: Descriptors of examples of adverse events (AE) 
AE#1: 
Medication – 
adverse drug 
reaction 
 
Patient was a 2 year old female. Quote from the medical record: 
"patient  halfway through IV flucloxacillin dose, onset of pruritis++ 
and cough - scratching 'like mad' " 
Patient has had increased itch with previous doses of flucloxacillin 
with the onset of symptoms ~5-10minutes after starting 
administration. This dose was different with the itch being unbearable 
and the new symptom of cough. 
This was Day 2 of IV flucloxacillin - dose 6. There was no mention in 
the nursing notes of itch during previous doses although evening shift 
on day one stated that patient would not settle until IV antibiotics were 
finished. 
IV flucloxacillin ceased after resident medical officer review as above. 
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AE#2: 
Medication – 
adverse drug 
reaction 
 
A 9 year old boy was previously diagnosed with ADHD and 
prescribed short acting methylphenidate (Ritalin) 10mg bd with 
symptoms well controlled.  The boy was seen by paediatrician who 
ceased the short acting methylphenidate and commenced him on a 
trial of extended release methylphenidate (Concerta) 27mg OD. 
One week later, the boy attended the general practitioner complaining 
of nausea, vomiting, abdominal pain, headache, insomnia, and audible 
hallucinations.   
The boy’s parents had already ceased the medication after 2 days 
before attending the general practitioner.  
The paediatrician was unavailable as they were on leave for 1 month.  
The general practitioner prescribed a trial of long-acting 
methylphenidate (Ritalin LA) 20mg OD. 3 months later, the GP noted 
that the long-acting methylphenidate (Ritalin LA) was ceased as 
ineffective and patient was recommenced on prescribed short acting 
methylphenidate ritalin 10mg bd by general practitioner and re-
referred to paediatrician at that visit. 
AE#3: 
Equipment – 
intravenous  
 
A 2 year old female patient was triaged on [date] in the emergency 
department for an infected intravenous catheter (IVC) site to right foot 
following discharge from [other hospital]. A registered nurse noted 
"tender red swollen ankle outer aspect, post recent IVC insertion 
under admission to [other hospital] for immunology work up. The 
IVC was removed and the patient was discharged yesterday. Patient’s 
mum noticed swelling, redness and limping this morning." Mum had 
brought the patient to her local hospital for review. Doctor reviewed 
and commenced patient on a week of oral sulfamethoxazole and 
trimethoprim (Bactrim) and flucloxacillin. 
 
AE#4: 
Equipment – 
insulin pump 
failure 
 
Insulin pump failure at home leading to DKA in 22 month old baby. A 
22 month old female baby was diagnosed at 16 months with Type 1 
Diabetes.  The baby had several admissions to hospital for fluctuating 
blood sugar levels (BSLs). The diabetes was under good control at 22 
months but there was an insulin pump failure at home. Mum was 
unable to closely monitor BSL and baby developed diabetic keto-
acidosis. Mum quickly realised problem and took the baby to the 
emergency department where an insulin infusion was set up and care 
attended. The baby quickly stabilised and was able to be discharged 
home with proper equipment. 
AE#5: 
Clinical 
process / 
procedure – 
diagnostic 
adverse 
events 
Parents took child to general practitioner in morning with symptoms 
diabetes, including drowsiness, reduced food intake and weight loss of 
3 kg over 3 weeks. The general practitioner gave infant anti-emetic 
and sent child home. Parents became concerned and took child to the 
emergency department on the same day where he was treated and 
transferred to a tertiary Hospital. By time of emergency department 
admission child showing increasing signs of drowsiness and diabetic 
keto-acidosis. Very close call if relative (who was home with the 
parents) was not aware of seriousness of child. Child not far from 
diabetic coma. 
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AE#6: 
Clinical 
process / 
procedure – 
procedural 
complications 
16 year old female presented to the emergency department with 
complaints of bleeding from a surgical wound post-tonsillectomy 5 
days previous. Also complained of throat pain and dizziness. On 
examination, blood pressure was low and a dark clot had formed in 
right tonsillar fossa. Patient was commenced on antibiotics and 
transferred to tertiary care facility. 
Wrong dose 
Seven adverse events involved “wrong dose”, all overdoses. Three overdoses involved 
teenage patients in diabetic keto-acidosis (DKA); whilst the other conditions (and IV / 
medications) involved asthma (salbutamol), pneumonia with a complex presentation 
(sedative), head injury (fluids), and bronchiolitis (gentamicin).  
Equipment adverse events 
Intravenous catheters access and use 
Thirty-two adverse events related to problems with intravenous (IV) access in children aged 
between 11 days and 15 years (see Table 5, AE#3). Of these, three quarters (24/32, 75%) 
were associated with infiltration or extravasation of fluid into tissues. Other problems were 
IV site infection (n=3), multiple attempts at insertion (n=2), re-cannulation injury (n=2) and 
an IV cannula being in situ for six days. The emergency department was identified as being 
the location of IV insertion for nearly half the adverse events (14/32, 44%).  
Insulin pump failures leading to wrong doses 
There were four adverse events related to insulin pump failures with patients at home, with 
three resulting in hyperglycaemia and one DKA (Table 5, AE#4). Patient ages ranged from 
22 months to 13 years. Three patients’ signs resolved with management at the emergency 
department, with one needing to be admitted overnight. There was one other adverse event 
involving an insulin pump which involved a patient admitted to hospital with hyperglycaemia 
on a background of cellulitis at the insertion site of insulin pump. 
Other equipment adverse events 
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In 15 adverse events a problem related to medical devices not already reported as IVCs or 
insulin pumps was identified. These included four adverse events that involved face masks all 
causing pressure ulcers, skin tears or blisters, and two incidents involved tourniquets, one 
with a rash and another with pain and discoloration due to being applied too tightly.  
Clinical process / procedure adverse events  
Diagnostic adverse events 
Twelve adverse events involved delayed or failed diagnosis, nearly one-third (12/38, 32%) of 
the clinical process/procedure adverse events (Table 5, AE#5). Two related to children 
presenting with multiple complex conditions. The conditions included were acute 
gastroenteritis, diabetes with previous multiple visits to the general practitioner, brain tumour, 
head injury, tonsillitis, bronchiolitis, ADHD, respiratory failure, and tracheobronchomalacia 
(likely treated on seven occasions as croup).  
Procedural complications 
There were 11 procedural complications (11/38, 29% of the clinical process/procedure 
adverse events) with six of these related to tonsillectomy or adenotonsillectomy (Table 5, 
AE#6). Four of these tonsillectomy or adenotonsillectomy adverse events were associated 
with bleeds; the age range was 3 to 16 years old, and they presented 6-10 days post-
operatively. Two other patients aged 4 or less presented unwell post-tonsillectomy, at 
emergency departments. Two patients had laparoscopic appendicectomy complications – one 
with a fluid collection (presented 4 days post-operatively) and one with vomiting and 
epistaxis on the same day. A 4-year old patient with presented a large bleed post-operative 
circumcision on day 2 and then another bleed on day 5. Two other complications were feeling 
faint and nauseous after a blood test and a breakdown of a gastrostomy button site.  
Discussion 
In our review of 232 adverse events detected by the GTT, 86% were related to the three most 
frequently occurring incident types – “medication”, “clinical process/procedure”, and 
“equipment”. Some three-quarters of these involved only minor harm to the patient. There 
was a greater proportion of adverse events resulting in higher severity of harm to patients in 
the clinical process/procedure category (40% vs 16% in all categories).  
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Incident types frequently reported in this study relate to problems commonly encountered in 
paediatric emergency departments and hospitals - medications and IV lines/access. Nearly 
half (48%) of the adverse events in this study were related to medications. Whilst other 
paediatric GTT studies report medication incidents (Table 6), they are generally related to 
adverse drug reactions associated with medication triggers of the GTT. These studies do not 
disaggregate the incident types to identify more specific types such as “wrong dose”. The 
identification of problems with wrong dose are not surprising, with many drug dosages in 
paediatrics posing challenges including being calculated individually, based on each patient’s 
age, weight or body surface area.38  
The subject of the World Health Organisation’s Third Global Patient Safety Challenge is 
Medication Without Harm, and our study has re-emphasised the frequency of occurrence of 
medication incidents in healthcare. Given that the steps in the medication pathway in 
hospitals are complex and interconnected, substantial improvements in medication safety 
require comprehensive systems, human-factors, and technological approaches that integrate 
all aspects of the medication pathway.39 Our study is also a reminder that medication risks 
manifest in the community, for example, related to central nervous stimulants for children 
with ADHD.  
Over one in five of the adverse events related to equipment (22%) with nearly two-thirds of 
these (32/51, 63%) IV lines/access. This is an unusual finding for studies collecting adverse 
events in the paediatric population using the GTT – the only other study having >5% of 
adverse events related to IVs was Unbeck et al (2014)(Table 6).8 The management of 
virtually all emergencies involves an IV line, whether for medication, fluids, blood products, 
or contrast injection.40 Although significant harm related to IV was not detected in this study, 
the extravasation of any IV fluid, site infection, haematoma, and phlebitis can cause serious 
and potentially permanent harm.40 Adverse events associated with IV access are largely 
preventable, although the safe management of IV lines requires many reliable processes to be 
undertaken over hours or days.40 Our study may point to further quality improvement projects 
being warranted in emergency departments and inpatient units related to management of IV 
lines.41 
Table 6: Healthcare setting and incident types as a % of adverse events in paediatric GTT 
studies for incident types with a greater than 5% frequency in our studya 
Study Hibbert (2020) – 
this paper 
Chapman 
(2014)7 
Solevag 
(2014)10 
Kirkendall 
(2012)6 
Unbeck 
(2014)8 
Matlow 
(2012)4 
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Healthcare 
setting 
Hospital, general 
practice, specialist 
peadiatrician 
Hospital Hospital Hospital Hospital Hospital 
Incident type 
Adverse Drug 
Events 
48 10b 6c 68d   23e 14f 
IV problems 14 g g g   7h g 
Non-IV 
equipment 
problems 
  7 g g g g g 
Diagnostic 
issues 
  5 g g g g 14i 
Procedural 
complications 
  5 18j 35j 13k 4l 15m 
Healthcare 
associated 
infections 
  5   9n 19o 11p 15q g 
Total (%) of 
AEs related 
to the main 
categories in 
this study 
76 37 60 92 49 43 
Adverse event 
types with 
>5% not in 
our study 
 Tissue 
damage or 
pressure 
ulcer (8%)r 
s  Skin and 
blood vessel 
harm. 
Thrombophl
ebitis 
(17%); pain 
(21%); 
transfusion 
(12%); 
failures in 
cardiovascul
ar, 
respiratory, 
or 
neurological 
function 
(19%); 
induced 
delivery 
(15%)t 
Surgical 
(33%); other 
clinical 
management 
(20%) 
 
a-Studies were included in the table if they accessed “generic” adverse events or incidents in peadiatrics. Stockwell et 
al(2018)9 was excluded, because although this study used a comprehensive classification system, it was very different to the 
system used in Table 6 and there was no congruence between the categories in Table 6 and Stockwell et al (2018) 
b- Anti-emetic given, abrupt medication stop, hypoglycaemia (<3mmol/L), drug level out of range, chlorpheniramine given, 
high INR (>5) or APTT>100s, naloxone given, vitamin K given (except for routine neonatal dose), flumazenil given.  
c – hygoglycaemia (<3 mmol/L) 
d – Total medication triggers 
e - Other side-effect of drug or anaphylactic reaction or unplanned drug withdrawal or naloxone administration, or rising 
serum creatinine or antidote administration or partial thromboplastin time (PTT) greater than 100 seconds or glucose 
<3mmol/liter or administration of 300mg/ml or 500 mg/ml glucose or vitamin K administration (excluding newborns) or too 
high or too low drug concentration 
f – Drug 
g – equivalent code not used in the study 
h - Infiltration/extravasation of intravenous injection/infusion 
i – Diagnostics error 
j - Complication of procedure or treatment 
k - Any procedure complication or any operative complication 
l - Occurrence of any postoperative complication or anesthesia related harm 
m - Medical procedure 
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n – Surgical site infection or nosocomial pneumonia or positive blood culture 
o – Positive blood culture or nosocomial pneumonia or surgical site infection or hospital acquired urinary tract infection 
p - Health care-associated infection of any kind 
q – Positive culture from central line catheter or insertion site or ventilator associated pneumonia or post-operative infection 
or fungal infection or other infection or pneumonia or antibiotic treated urinary tract infection or viral gastroenteritis or  
clostridium difficile positive stool or positive bold culture or pneumonia 
r – Readmission to hospital and unplanned admission were both >5% however they are consequences of an adverse event not 
an adverse event type 
s – Transfer to a higher level of care type was >5% however it is a consequence of an adverse event not an adverse event 
t – Occurrence of mistake and readmission within 30 days were >5% but were not adverse event types 
Delayed or failed diagnose comprise about one-third of the clinical process/procedure 
adverse events and 5% of all. The conditions involved are highly varied and no pattern 
emerges from the low number of adverse events involved. Matlow et al (2012) was the only 
other paediatric GTT study which reported diagnostic problems in 5% or more of adverse 
events (14%)(Table 6).4 In a study analysing incidents related to primary care and paediatrics, 
2% were associated with diagnosis or failure to identify high-risk patients.42 Diagnostic 
incidents are under-recognised as a patient safety issue because of the difficulty in detecting 
and measuring them,43, 44 even though about one in ten people have reported that they, or 
someone close to them, has experienced a diagnostic error.45 They present a particular 
challenge for incident reporting systems due to difficulty in defining them precisely, they 
seldom comprise a concrete, identifiable ‘event’, and doctors, who are most likely to be 
involved in diagnostic incidents, are less likely than other health care staff (e.g. nurses) to 
report incidents.46 The GTT is likely to provide a more targeted method of identifying 
diagnostic adverse events than incident reporting systems, however it needs to be 
complemented with other detection methods including medico-legal claims analysis, 
algorithmic surveillance of electronic medical and medication records, reviews of diagnostic 
testing results, and clinician and patient surveys.47 Organisations should consider using the 
GTT to detect and characterize incident types such as diagnostic problems that are under-
reported in incident systems.2  
Our study reviewed records across a variety of healthcare provider types, unlike the rest of 
the studies in Table 6 which just reviewed records in hospitals. We also included some 
chronic conditions that are mainly managed outside hospital, e.g., AHDH and depression. 
This and that CareTrack Kids conditions did not include surgical conditions, may partially 
explain some differences in incident type profiles between our and other studies. For 
example, the percentage of procedural complications in our study was 5%, which is at the 
lower range of other studies (4-35%).6, 7, 8, 10  
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There has been only one other generic paediatric study characterising the incident types of 
adverse events detected by the GTT in a detailed manner.9 However, this study classified the 
adverse events using body systems as the primary classification and the results are not 
directly comparable to our study, and therefore, was not included in Table 6.9 The other 
studies tend to report adverse events against the GTT triggers. The type of adverse event can 
be inferred from some of these triggers, for example surgical site infection or nosocomial 
pneumonia, but the types could be unclear, with, for example, triggers related to readmission 
or medication stop.  Five studies reported adverse events type aligned with the trigger 
descriptors,5-8, 10 with one of these also reporting the specialty in association with where the 
adverse event occurred.10 Another study reported high level incident types and specialty 
(Table 6).4 The qualitative approach taken in our study has allowed a more specific 
characterisation of the types of adverse events experienced by a paediatric population and 
will permit future focussed analyses to understand their underlying causal mechanisms.35, 42 
Strengths and weaknesses 
Although there are other studies using the GTT in paediatric care,4-10, 13, 15, 48-51 they 
infrequently focus on characterising the adverse events detected. Generic problems with 
using the GTT have been identified previously and are pertinent to this study. These include 
completeness and layout of medical records at different health services, differing 
interpretations by reviewers, and hindsight bias.2 Due to logistical issues, with healthcare 
providers separated by up to 3,000 kilometres, only one nurse surveyor undertook the 
medical record reviews in this study. 
The cognitive load on the surveyors was high, as they were also reviewing medical records 
for a parallel study on quality of care.20 Records were then re-reviewed to search for adverse 
events, using different trigger tools depending on the provider types. This may have 
contributed to the surveyors inadvertently “missing” adverse events, leading to a lower rate of 
adverse events detected. On the other hand, reviewing the record a number of times may, in 
some cases, have increased the surveyor’s level of familiarity with the medical record.  
Conclusion 
Adverse drug reactions and issues with IV lines or access were frequently identified adverse 
events in our study. Other adverse events such as those associated with wrong or delayed 
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diagnoses, overdose, and problems with insulin pumps were also identified. We identified 
and characterised those adverse events which is the first step in understanding causal 
mechanisms and developing quality improvements in practice. There may be some adverse 
event types, such as diagnostic issues, that are more suited to collect by the GTT and other 
methods rather than incident reporting.  
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